Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hohenfellner

Showing results (71-80 of 277) with videos related to

Pageof 28
Sort By:
Journal of Computer Assisted Tomography|November 4, 2006
Multislice computed tomography in planning nephron-sparing surgery in a prospective study with 76 patients: comparison of radiological and histopathological findings in the infiltration of renal structuresPeter Hallscheidt, Nina Wagener, Farshad Gholipour, et al.
Journal of Neuro-Oncology|August 20, 2016
Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinomaYueJun Du, Sascha Pahernik, Boris Hadaschik, et al.
Urologic Oncology|October 4, 2016
Molecular complexity of taxane-induced cytotoxicity in prostate cancer cellsJosef Mang, Konstanze Merkle, Martina Heller, et al.
Surgical Endoscopy|October 20, 2020
Evaluation of new motorized articulating laparoscopic instruments by laparoscopic novices using a standardized laparoscopic skills curriculumDaniel Uysal, Claudia Gasch, Rouven Behnisch, et al.
Urologic Oncology|January 8, 2016
Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrenceCarsten Grüllich, Sonia Vallet, Christopher Hecht, et al.
Translational Oncology|September 18, 2017
Expression and Functional Characterization of the BNIP3 Protein in Renal Cell CarcinomasStephan Macher-Goeppinger, Martina Keith, Gencay Hatiboglu, et al.
Oncotarget|October 28, 2015
The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarkerMaximilian Knoll, Stephan Macher-Goeppinger, Jürgen Kopitz, et al.
Frontiers in Oncology|December 25, 2024
Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatmentViktoria Schütz, Christopher-Leo Nessler, Anette Duensing, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 2011
Molecular heterogeneity of TFE3 activation in renal cell carcinomasStephan Macher-Goeppinger, Wilfried Roth, Nina Wagener, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
Repeated <sup>177</sup>Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBqHendrik Rathke, Frederik L Giesel, Paul Flechsig, et al.
Pageof 28

Showing results (71-80 of 277) with videos related to

Sort By:
Pageof 28
Journal of Computer Assisted Tomography|November 4, 2006
Multislice computed tomography in planning nephron-sparing surgery in a prospective study with 76 patients: comparison of radiological and histopathological findings in the infiltration of renal structuresPeter Hallscheidt, Nina Wagener, Farshad Gholipour, et al.
Journal of Neuro-Oncology|August 20, 2016
Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinomaYueJun Du, Sascha Pahernik, Boris Hadaschik, et al.
Urologic Oncology|October 4, 2016
Molecular complexity of taxane-induced cytotoxicity in prostate cancer cellsJosef Mang, Konstanze Merkle, Martina Heller, et al.
Surgical Endoscopy|October 20, 2020
Evaluation of new motorized articulating laparoscopic instruments by laparoscopic novices using a standardized laparoscopic skills curriculumDaniel Uysal, Claudia Gasch, Rouven Behnisch, et al.
Urologic Oncology|January 8, 2016
Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrenceCarsten Grüllich, Sonia Vallet, Christopher Hecht, et al.
Translational Oncology|September 18, 2017
Expression and Functional Characterization of the BNIP3 Protein in Renal Cell CarcinomasStephan Macher-Goeppinger, Martina Keith, Gencay Hatiboglu, et al.
Oncotarget|October 28, 2015
The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarkerMaximilian Knoll, Stephan Macher-Goeppinger, Jürgen Kopitz, et al.
Frontiers in Oncology|December 25, 2024
Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatmentViktoria Schütz, Christopher-Leo Nessler, Anette Duensing, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 2011
Molecular heterogeneity of TFE3 activation in renal cell carcinomasStephan Macher-Goeppinger, Wilfried Roth, Nina Wagener, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
Repeated <sup>177</sup>Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBqHendrik Rathke, Frederik L Giesel, Paul Flechsig, et al.
Pageof 28